PARADIGM BIOPHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.285 AUD | 0.00% |
|
+3.64% | -32.94% |
Chart calendar Paradigm Biopharmaceuticals Limited
942909b7f2f9.i5WlVOyqKyzRkvwfZ4T2Eqc4FHitrtQ9TC-N9GWIHog.5MLMLpnjfRqJxrVtL-q-e_5eJB7l5oB4O2zfmgu_dfDA0eQ8ucVSXabfuQ~f3acd0f3fc1a13c78010363c8bef32dd
Upcoming events on Paradigm Biopharmaceuticals Limited
Past events on Paradigm Biopharmaceuticals Limited
| 2024-04-17 | OARSI World Congress |
| 2024-03-20 08:40 pm | NWR Virtual Healthcare Conference |
| 2024-02-27 08:15 pm | Q2 2024 Earnings Release |
| 2024-02-01 | Orthopaedic Research Society Meeting |
| 2024-01-30 04:48 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2023-11-28 05:00 pm | Annual General Meeting |
| 2023-10-29 06:04 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-10-17 | PARA_OA_008 Phase II Clinical Trial Results Call |
| 2023-10-09 | PARA_OA_008 Phase 2 clinical trial Results Call |
| 2023-08-25 01:53 am | Q4 2023 Earnings Release |
| 2023-07-30 09:58 pm | June 2023 Sales and Revenue Release - Activities Reporet |
| 2023-07-19 | MST Access Biotech Hidden Gems Forum |
| 2023-04-28 12:24 am | March 2023 Sales and Revenue Release - Activities Reporet |
| 2023-04-03 07:30 pm | PARA_OA_008 Clinical Trial Results Call |
| 2023-03-21 10:00 pm | NWR Virtual Healthcare Conference |
| 2023-03-16 | Osteoarthritis Research Society International World Congress |
| 2023-02-26 05:57 pm | Q2 2023 Earnings Release |
| 2023-02-21 | WORLD Symposium |
| 2023-02-19 | Lysosomal Diseases International Conference |
| 2023-01-30 | December 2022 Sales and Revenue Release - Activities Reporet |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 3,25 3,00 8.19% | 4,70 2,63 78.86% | 8,94 3,40 162.99% | 0,08 0,00 - | 0,05 0,01 367.6% | 0,00 |
|
EBITDA Million AUD | Released Forecast Spread | -8,69 -6,00 -44.84% | -12,1 -15,5 22% | -34,0 -35,0 2.58% | -39,0 -56,6 31.05% | -51,7 -59,0 12.31% | -52,5 |
|
EBIT Million AUD | Released Forecast Spread | -8,70 -6,00 -44.98% | -12,3 -15,5 20.62% | -34,3 -35,0 1.98% | -39,2 -56,6 30.71% | -51,9 -59,0 12.04% | -52,5 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -15,6 -5,80 -169.44% | -12,3 -14,4 14.6% | -34,3 -35,8 4.06% | -39,2 -55,4 29.15% | -51,9 -58,5 11.26% | -52,0 |
|
Net income Million AUD | Released Forecast Spread | -15,6 -5,80 -169.44% | -12,3 -14,4 14.6% | -34,3 -33,7 -1.92% | -39,2 -55,4 29.15% | -51,9 -58,5 11.26% | -52,0 |
|
EPS AUD | Released Forecast Spread | -0,11 -0,04 -187.63% | -0,06 -0,07 18.05% | -0,17 -0,15 -13.49% | -0,17 -0,24 30.29% | -0,21 -0,20 -3.9% | -0,18 |
| Announcement Date | 30/08/19 | 27/08/20 | 26/08/21 | 25/08/22 | 25/08/23 | - |
Quarterly results
| Fiscal Period | June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 |
|---|---|---|---|---|---|
|
EBITDA Million AUD | Released Forecast Spread | -13,4 -14,9 9.79% | |||
|
EBIT Million AUD | Released Forecast Spread | -13,5 -14,8 8.46% | -12,3 -29,6 58.61% | ||
|
Net income Million AUD | Released Forecast Spread | -20,7 | -27,0 | ||
|
EPS AUD | Released Forecast Spread | -0,09 | -0,12 | ||
| Announcement Date | 24/02/21 | 26/08/21 | 23/02/22 | 25/08/22 |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| 2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for Paradigm Biopharmaceuticals Limited
| Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PAR Stock
- Calendar Paradigm Biopharmaceuticals Limited
